Participant flow

Bortezomib (Velcade) in Patients With Untreated Multiple Myeloma · Source last updated 2019-06-11

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Participants received intravenous bortezomib on a 3-week dosing cycle: 1.3 mg/m2 on days 1, 4, 8 and 11 followed by 10 day rest period for up to 8 cycles or for 2 cycles beyond complete response. Participants with progressive disease or unacceptable toxicity discontinued treatment.

   id

   FG000

   title

   Bortezomib

periods

1. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         9

      type

      Adverse Event

   2. reasons

      1. group Id

         FG000

         num Subjects

         9

      type

      Progressive Disease

   3. reasons

      1. group Id

         FG000

         num Subjects

         3

      type

      Physician Decision

   4. reasons

      1. group Id

         FG000

         num Subjects

         3

      type

      Lack of Response

   5. reasons

      1. group Id

         FG000

         num Subjects

         2

      type

      Death

   6. reasons

      1. group Id

         FG000

         num Subjects

         1

      type

      Withdrawal by Subject

   7. reasons

      1. group Id

         FG000

         num Subjects

         1

      type

      Non-Protocol Therapy

   8. reasons

      1. group Id

         FG000

         num Subjects

         1

      type

      Withdrawal of Consent before Trt

   9. reasons

      1. group Id

         FG000

         num Subjects

         1

      type

      Progressive Disease before Trt

   milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         66

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         64

      type

      Eligible and Treated

   3. achievements

      1. group Id

         FG000

         num Subjects

         36

      type

      COMPLETED

   4. achievements

      1. group Id

         FG000

         num Subjects

         30

      type

      NOT COMPLETED

   title

   Overall Study

recruitment Details

66 participants were enrolled between December 2003 and September 2005.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice